These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3091409)

  • 1. Sonography of the endometrium during conception and nonconception cycles of in vitro fertilization and embryo transfer.
    Fleischer AC; Herbert CM; Sacks GA; Wentz AC; Entman SS; James AE
    Fertil Steril; 1986 Sep; 46(3):442-7. PubMed ID: 3091409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET.
    Jung H; Roh HK
    J Assist Reprod Genet; 2000 Jan; 17(1):28-33. PubMed ID: 10754780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer.
    Dlugi AM; Laufer N; DeCherney AH; MacLusky NJ; Haseltine FP; Polan ML; Mezer HC; Tarlatzis B; Naftolin F
    Fertil Steril; 1984 Apr; 41(4):530-7. PubMed ID: 6231193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound measurement of endometrial thickness on different ovarian stimulation regimens during in-vitro fertilization.
    Imoedemhe DA; Shaw RW; Kirkland A; Chan R
    Hum Reprod; 1987 Oct; 2(7):545-7. PubMed ID: 3119658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
    Ben-Rafael Z; Benadiva CA; Ausmanas M; Barber B; Blasco L; Flickinger GL; Mastroianni L
    Fertil Steril; 1987 Dec; 48(6):964-8. PubMed ID: 3119377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between preovulatory serum 17 beta-estradiol pattern and conception in human menopausal gonadotropin-human chorionic gonadotropin stimulation.
    Laufer N; DeCherney AH; Tarlatzis BC; Naftolin F
    Fertil Steril; 1986 Jul; 46(1):73-6. PubMed ID: 3087791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome in women with a single ovary versus patients with two ovaries undergoing in vitro fertilization and embryo transfer (IVF/ET).
    Levitas E; Furman B; Shoham-Vardi I; Lunenfeld E; Potashnik G
    Eur J Obstet Gynecol Reprod Biol; 2000 Feb; 88(2):197-200. PubMed ID: 10690680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effect of a homogeneous hyperechogenic endometrial sonographic pattern, despite adequate endometrial thickness on pregnancy rates following in-vitro fertilization.
    Check JH; Lurie D; Dietterich C; Callan C; Baker A
    Hum Reprod; 1993 Aug; 8(8):1293-6. PubMed ID: 8408530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro fertilization: the degree of endometrial insufficiency varies with the type of ovarian stimulation.
    Sterzik K; Dallenbach C; Schneider V; Sasse V; Dallenbach-Hellweg G
    Fertil Steril; 1988 Sep; 50(3):457-62. PubMed ID: 3137101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.
    Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M
    J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pregnancy rate of in vitro fertilization and embryo transfer in women aged 40 and over with basal uterine artery pulsatility index.
    Chiang CH; Hsieh TT; Chang MY; Shiau CS; Hou HC; Hsu JJ; Soong YK
    J Assist Reprod Genet; 2000 Sep; 17(8):409-14. PubMed ID: 11062849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern.
    Rashidi BH; Sadeghi M; Jafarabadi M; Tehrani Nejad ES
    Eur J Obstet Gynecol Reprod Biol; 2005 Jun; 120(2):179-84. PubMed ID: 15925048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.